BioSpace

Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma

Advocates are sounding the alarm on social media as they learn from their doctors that Novartis has received reports of tumors in patients who have been treated with the spinal muscular atrophy gene therapy.

By BioSpace

1 min read
Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights